Skip to content

GREYLOCK XII GP LLC

Follow

13F filer, CIK 1413877, Menlo Park, CA

GREYLOCK XII GP LLC reported $142,038,000 across 4 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-01.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-18-010399

Period
2018-09-30
Reported value
$142M
Holdings
4
Top 10 weight
100%
New
2
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KALA BIO INC COMnew+199,613$1.97M
RYTMnew+54,749$1.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q3 2018

Share positions as resolved from 13F-HR 0000950123-18-010399, largest first. % of portfolio is the value over $142,038,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REDFIN CORPREDFIN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: 8,309,512 shares; 2018Q1: 6,243,262 shares; 2018Q2: 4,177,012 shares; 2018Q3: 4,177,012 shares 4,177,012$78.1M54.99%0
CLOUDERA INCCLOUDERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: 6,744,865 shares; 2018Q1: 6,744,865 shares; 2018Q2: 3,419,865 shares; 2018Q3: 3,419,865 shares 3,419,865$60.4M42.5%0
KALA BIO INC COMKALA BIO INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 199,613 shares 199,613$1.97M1.39%new
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 54,749 shares 54,749$1.6M1.12%newTimeline

How Q3 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-18-010399 base2018-11-01acceptance time not in the bulk data set